Ionis Pharmaceuticals (MEX:IONS) Machinery, Furniture, Equipment : MXN0 Mil (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Ionis Pharmaceuticals Machinery, Furniture, Equipment?

Ionis Pharmaceuticals's Machinery, Furniture, Equipment for the quarter that ended in Sep. 2024 was MXN0 Mil.

Ionis Pharmaceuticals's annual Machinery, Furniture, Equipment declined from Dec. 2021 (MXN1,711 Mil) to Dec. 2022 (MXN1,636 Mil) and declined from Dec. 2022 (MXN1,636 Mil) to Dec. 2023 (MXN1,523 Mil).

Ionis Pharmaceuticals Machinery, Furniture, Equipment Historical Data

The historical data trend for Ionis Pharmaceuticals's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ionis Pharmaceuticals Machinery, Furniture, Equipment Chart

Ionis Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Machinery, Furniture, Equipment

Get a 7-Day Free Trial

1,288.50

1,628.38

1,710.72

1,636.22

1,523.08

Ionis Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Machinery, Furniture, Equipment	Get a 7-Day Free Trial															-	1,523.08	-	-	-

Ionis Pharmaceuticals Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

Ionis Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ionis Pharmaceuticals Inc (MEX:IONS) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

IONS:USA 0JDI:UK ISI:Germany ISI:Germany

Address

2855 Gazelle Court, Carlsbad, CA, USA, 92010

Website

https://www.ionispharma.com

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024.